Skip to content
Screener

Phathom Pharmaceuticals, Inc. PHAT NJ — Lessee Operating Lease Number Of Option To Extend

Similar metrics at other companies

Hope Bancorp logo
HOPELessee Operating Lease Optionto Extend Numberof Leases Extended
$4+33.3%
Kodiak Sciences Inc logo
KODCA — Lessee Operating Lease Option To Extend
$6.5
Mama's Creations, Inc. logo
MAMAFarmingdale — Number of options to extend lease
20.0%
Kodiak Sciences Inc logo
KODCA — Number Of Options To Extend Lease Term
2
Ardelyx logo
ARDXNumber of options to extend
10.0%
Ardelyx logo
ARDXNumber of options to extend
$10.0%

Other financials

Income statement

See full
Revenue$74.3M+88.0%
Gross profit$59.2M+71.7%
Operating income-$4.0M+93.4%
Net income-$17.6M+76.8%
EPS (diluted)-$0.21+80.0%

Balance sheet

See full
Cash & equivalents$182.5M+22.0%
Total debt$167.1M-18.9%
Total equity-$344.3M+15.2%
Total assets$327.1M+30.7%

Cash flow

See full
Operating cash flow-$1.9M+96.9%
CapEx$44.0K-54.6%
Free cash flow-$2.0M+96.9%

Valuation

See full
Market cap$691.7M-5.2%
Enterprise value$676.34M-13.9%
P/S2.9×-3.5×

Profitability

See full
Gross margin82.9%-4.0pp
Operating margin-17%-8.2pp
Net margin-41.3%-19.1pp
FCF margin-15.4%-7.4pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept phat:LesseeOperatingLeaseNumberOfOptionToExtend.

The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 7:05 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-193946

As of March 31, 2026, the Company had operating leases for office space in both Buffalo Grove, Illinois and Florham Park, New Jersey, with weighted average remaining lease terms of 4.2 years and 4.9 years, respectively. In September 2025, the Company entered into amendments to its lease agreements for the New Jersey office space to extend the terms of the leases through February 2031. All operating leases contain an option to extend the term for one additional five year period, which was not considered in the determination of the right-of-use asset or lease liability as the Company did not consider it reasonably certain that it would exercise such options.

Item 1. Financial Statements (unaudited)

FAQ

What is Phathom Pharmaceuticals, Inc.'s NJ — lessee operating lease number of option to extend?
Phathom Pharmaceuticals, Inc. (PHAT) reported NJ — lessee operating lease number of option to extend of 1 in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s NJ — lessee operating lease number of option to extend changed year-over-year?
Phathom Pharmaceuticals, Inc.'s NJ — lessee operating lease number of option to extend decreased by 0.0% year-over-year, from 1 to 1.
What does NJ — lessee operating lease number of option to extend mean?
This metric represents the total count of contractual options available to the company to extend the lease term for operating assets within the specified geographic or operational segment. It provides insight into the company's flexibility to maintain its physical footprint and operational continuity in a specific region. Monitoring this count helps investors assess potential future lease commitments and the strategic optionality regarding facility usage.

Ask your AI about Phathom Pharmaceuticals, Inc.'s nj — lessee operating lease number of option to extend.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude